Courtesy of of Dr. Rutherford
Here is the latest science and news about obesity and GLP-1 meds like Zepbound, Wegovy, Ozempic, Terzipitide, Mounjaro.
America’s Obesity Crisis:
Dr. Explains Problem Plaguing 75% of U.S. Adults |
Amanpour and Company
A new Biden proposal for coverage of obesity drugs by Medicare and Medicaid coincides with a report finding that 75% of American adults are overweight or obese. The numbers have been trending upward since 1990. Dr Fatima Cody Stanford is an obesity medicine physician and professor at Harvard Medical School. As medications like Ozempic become household names, Stanford joins the show to discuss treating obesity. Originally aired on November 26, 2024.